Cansartan-Mepha 32, Tabletten - 28 Tablette(n) Swissmedic Key 60929013 Registration Holder Mepha Pharma AG Name Cansartan-Mepha 32, Tabletten Date of registration 30.11.2010 Original/Generic Generic Introduction of Sequence 30.11.2010 ATC-Classification Candesartan (C09CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 28 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 12.31 Limitation No Deductible 10 % Consumer price 29.85 Feedback FB Daily cost GTIN 7680609290137 Medication Code Synthetika Pharmacode 5429682 Disponibility
Composition candesartanum cilexetilum 32 mg, maydis amylum, lactosum monohydricum 243.6 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.96 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 32 mg
BAG: Active Agent Dose Candesartanum Cilexetil 32 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 243.6 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 05.08.2020
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :